Drs. Manojkumar Bupathi and Benjamin Garmezy are expert healthcare providers in oncology and genitourinary cancers. Dr. Garmezy, of Sarah Cannon Research Institute, serves as the Associate Director of Genitourinary Research for the national network as well as the Co-Chair of the Executive Research Committee where he oversees investigational therapy trials for GU cancers, including prostate, kidney, testicular, and bladder cancers. Dr. Bupathi is a board-certified medical oncologist specializing in genitourinary cancers including adrenal, bladder, kidney, penile, prostate, and testicular. He was recently elected practice president for Rocky Mountain Cancer Centers and serves as the Co-Chair for US Oncology Genitourinary Cancer Research Program.

Dr. Calais is a nuclear medicine physician who specializes in cancer imaging and theranostics. He is an associate professor at the David Geffen School of Medicine, director of the UCLA Theranostics Program, and director of the Clinical Research Program of the Ahmanson Translational Theranostics Division. He conducts investigator-initiated and industry-sponsored clinical trials of targeted molecular imaging and radio nuclide therapy.

Dr. Marshall is an assistant professor of oncology at Johns Hopkins in Baltimore, Maryland, and cohost of the Harrison’s Podclass podcast.